Current:Home > FinanceWhite House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly-InfoLens
White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly
View Date:2024-12-23 11:15:30
WASHINGTON (AP) — The Biden administration said Thursday that drug price negotiations will knock hundreds of dollars — in some cases thousands — off the list prices of 10 of Medicare’s most popular and costliest drugs.
The discounts, agreed to after months of negotiations with drug manufacturers, range between 38% and 79% on the medication’s list price, which is the cost of medication before discounts or rebates are applied — not the price people actually pay for prescriptions.
Medicare spent $50 billion covering the drugs last year and taxpayers are expected to save $6 billion on the new prices, which do not go into effect until 2026. Older adults could save as much as $1.5 billion in total on their medications in out-of-pocket costs. Administration officials released few details about how they arrived at those calculations.
The newly negotiated prices will impact the price of drugs used by millions of older Americans to help manage diabetes, blood cancers and prevent heart failure or blood clots. The drugs include the blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia.
It’s a landmark deal for the Medicare program, which provides health care coverage for more than 67 million older and disabled Americans. For decades, the federal government had been barred from bartering with pharmaceutical companies over the price of their drugs, even though it’s a routine process for private insurers.
“For years, millions of Americans were forced to choose between paying for medications or putting food on the table, while Big Pharma blocked Medicare from being able to negotiate prices on behalf of seniors and people with disabilities,” President Joe Biden said in a statement. “But we fought back -– and won.”
The drug deals will become a focal point for Vice President Kamala Harris’ presidential campaign, especially since she cast the tiebreaking vote to pass the law. She will join Biden on Thursday to announce the drug prices, in what will be their first joint speaking appearance since she replaced him at the top of the Democratic ticket, as they both struggle to persuade voters that costs will trend down after years of above-normal inflation.
Harris is set to release part of her economic agenda on Friday in North Carolina, where she plans to detail other ways to help cut costs and boost incomes for the middle class.
The pair last appeared publicly together to welcome back to the U.S. Americans detained in Russia who were freed as part of a massive prisoner swap earlier this month.
Powerful drug companies unsuccessfully tried to file lawsuits to stop the negotiations, which became law in 2022, when a Democratic-controlled Congress passed the Inflation Reduction Act (IRA), overhauling several Medicare prescription drug regulations. But executives of those companies have also hinted in recent weeks during earnings calls that they don’t expect the negotiations to impact their bottom line.
Pharmaceutical officials blasted the news from the White House, saying it will spread health care costs to taxpayers in other ways, including their Medicare premiums.
“The administration is using the IRA’s price-setting scheme to drive political headlines, but patients will be disappointed when they find out what it means for them,” Steve Ubl, the president of the Pharmaceutical Research and Manufacturers of America (PhRMA). “The ironically named Inflation Reduction Act is a bad deal being forced on American patients: higher costs, more frustrating insurance denials and fewer treatments and cures for our loved ones.”
Next year, the Department of Health and Human Services can select another 15 drugs for price negotiations.
veryGood! (41448)
Related
- New Orleans marks with parade the 64th anniversary of 4 little girls integrating city schools
- Lax oversight by California agency put LA freeway at risk before 2023 blaze, audit finds
- Adam Levine Is Returning to The Voice: Meet His Fellow Season 27 Coaches
- No, you probably didn't win a free vacation. Don't let these scams ruin your summer fun
- 'Full House' star Dave Coulier diagnosed with stage 3 cancer
- Kerry Washington takes credit for 'Scandal' co-star Tony Goldwyn's glow up
- Florida revises school library book removal training after public outcry
- Louisiana lawmakers approve bill to allow surgical castration of child sex offenders
- Former West Virginia jail officer pleads guilty to civil rights violation in fatal assault on inmate
- Dollar Tree may shed Family Dollar through sale or spinoff
Ranking
- 25 monkeys caught but more still missing after escape from research facility in SC
- Slovakia’s Fico says he was targeted for Ukraine views, in first speech since assassination attempt
- US vs. Pakistan: Start time, squads, where to watch 2024 T20 Cricket World Cup match
- Lenny Kravitz Shares Sweet Insight Into His Role in Zoë Kravitz's Wedding to Channing Tatum
- American Idol’s Triston Harper, 16, Expecting a Baby With Wife Paris Reed
- King Charles III gives thanks to D-Day veterans during event with Prince William, Queen Camilla
- Sturgill Simpson to release new album under a new name, embark on 2024 concert tour
- Jennie Garth’s Daughter Fiona Looks All Grown Up in Prom Photos
Recommendation
-
Incredible animal moments: Watch farmer miraculously revive ailing chick, doctor saves shelter dogs
-
Georgia’s ruling party introduces draft legislation curtailing LGBTQ+ rights
-
Ikea is hiring real people to work at its virtual Roblox store
-
Travis Kelce Is Guilty as Sin of Letting Taylor Swift Watch This TV Show Alone
-
Colts' Kenny Moore II ridicules team's effort in loss to Bills
-
Online lottery player in Illinois wins $560 million Mega Millions jackpot
-
Nancy Lieberman on Chennedy Carter: 'If I were Caitlin Clark, I would've punched her'
-
Clubhouse programs take pressure off overwhelmed Texas mental health hospitals